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Abstract 
Enteropathogenic E. coli (EPEC) induces a severe watery diarrhea responsible for several 
hundred thousand infant deaths each year by a process correlated with the loss (effacement) of 
absorptive microvilli. Effacement is linked to the LEE (Locus of Enterocyte Effacement) 
pathogenicity island that encodes an ‘injection system’, ‘effector’ proteins and the Intimin outer 
membrane protein. Here, we reveal that effacement i) is a two-step process ii) requires the 
cooperative action of three injected effectors (Map, EspF, Tir) as well as Intimin and iii) leads to 
the retention, not release (into the extracellular milieu) of the detached microvillar material. We 
also discover that EPEC rapidly inactivates the sodium-D-glucose cotransporter (SGLT-1) by 
multiple mechanisms. Indeed, the finding that one mechanism occurs more rapidly than 
microvilli effacement provides a plausible explanation for the rapid onset of severe watery 
diarrhea, given SGLT-1’s crucial role in the daily uptake of ~6 liters of fluids from the normal 
intestine. The importance of SGLT-1 in the disease process is supported by severe EPEC 
diarrheal cases being refractory to oral rehydration therapy (dependent on SGLT-1 function). 
Moreover, the identification of effector activities that alter microvilli structure and SGLT-1 
function provides new tools for studying the underlying regulatory processes.  
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Introduction 
EPEC is the prototypical member of the attaching and effacing (A/E) family of pathogens that 
infect a number of mammalian species including humans (EPEC and enterohemorrhagic E.coli 
[EHEC]), rabbits, dogs, mice, cattle and sheep (1, 2). EPEC-mediated disease has been 
correlated for over four decades with intimate binding to enterocytes lining the small intestine, 
loss (effacement) of absorptive microvilli and recruitment of host cytoskeletal proteins beneath 
the adherent bacteria - the A/E lesion (1-3). These processes are mediated by the EPEC LEE 
pathogenicity island as transfer of this ~35Kb region into non-pathogenic E. coli strains confers 
the ability to induce such changes (4). The LEE encodes transcriptional regulators, a Type Three 
Secretion System (T3SS), translocators, injected ‘effectors’, chaperones and the Intimin outer 
membrane protein (1, 2, 5). The T3SS/translocators function together to deliver both LEE- and 
non-LEE-encoded proteins into the host cell.  
The T3SS/translocator system, Intimin and Tir are all essential virulence determinants 
presumably due to their roles in intimate adherence – a process that requires the T3SS-dependent 
insertion of Tir into the plasma membrane to act as a receptor for bacterial binding via Tir-
Intimin interaction (6-8). However, Tir-Intimin interaction also triggers signaling cascades 
leading to responses including phosphorylation of a host phospholipase and recruitment of 
cytoskeletal proteins beneath the adherent bacteria (5, 9). Intimin can also subvert cellular 
processes independently of Tir (5).  The LEE encodes five additional effectors namely Map, 
EspF-H & Z (5, 10), though the translocator proteins may also have signaling functions (11). 
While relatively little is known about the functions of these molecules in disease, the 
multifunctional nature of LEE-effectors has been established as well as their ability to act 
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together in redundant, synergistic and/or antagonistic mechanisms to alter host cellular processes 
(5, 12-19).  
A lack of success in identifying the LEE-effectors responsible for effacement is 
indicative of either i) roles for unidentified effectors ii) signaling functions for the translocator 
proteins and/or iii) a requirement for multiple effector molecules in the process. In this study, 
scanning electron microscopy analysis of differentiated Caco-2 cells (small intestinal epithelial 
model) infected with wild type EPEC versus mutants deleted for one or more LEE-encoded 
effectors identified a two-step effacement process dependent on the cooperative action of four 
LEE proteins. The additional discovery that effaced microvilli material is not released into the 
extracellular milieu led to the development of a biochemical assay to monitor this event and in 
fact identified a potent diarrheagenic mechanism to possibly explain the rapid onset of severe 
watery diarrhea (20). The implications of the data to understanding both EPEC pathogenic and 
host cellular processes are discussed.  
 
Results 
Generation of a biochemical assay to monitor EPEC T3SS-dependent effacement 
EPEC interaction with human small intestinal enterocytes is extensively modeled using 
differentiated Caco-2 cells as they share many characteristics including epithelial barrier function 
and absorptive microvilli (21). Routine evaluation of EPEC-induced effacement by scanning and 
transmission electron microscopy (SEM/TEM) (4, 22-24) is indicative of obstacles in generating 
more quantitative biochemical-based assays. This premise was supported by the inability to 
detect significant T3SS-dependent release of three microvillar-associated enzyme activities, 
including alkaline phosphatase (AP), following EPEC infection of Caco-2 cells (not shown). 
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This apparent paradox was resolved by confocal microscopic analysis which consistently 
revealed the relocation of the majority of AP from the actin-rich brush border to a location above 
the adherent bacteria (Fig. 1A) in a T3SS-dependent manner (data not shown). This prompted the 
development of a quantitative assay based on the sodium-D-glucose cotransporter (SGLT-1) as 
its relocation from the apical surface membrane would prevent the import of glucose, or the non-
metabolisable analogue α-methyl-D-glucopyranoside (AMG), due to the requirement of an 
intracellular sodium gradient (25). The appropriateness of this protein as an effacement marker 
was supported by its T3SS-dependent relocation, as with AP (Fig. 1A), to a position above the 
actin-rich brush border (Fig. 1B). 
Measuring SGLT-1 cellular activity following 30 min synchronized infections with pre-
activated bacteria (induces T3SS) over a range of MOI (multiplicity of infection) supported the 
use of this assay to monitor effacement. Thus, while no significant decrease in SGLT-1 activity 
was recorded with the espA (translocator defective) mutant, wild type EPEC induced a dose-
dependent decrease with the highest MOI practically abolishing this cellular activity (Fig. 2A) by 
a process linked to bacteria covering the entire apical surface (Fig. 2B). However, MOI’s of 
~50:1 and ~200:1  (bacteria:host cell) resulted in bacteria covering only ~8% and 37% of the cell 
surface, respectively (Fig. 2B) but inhibited ~25% and ~85% of the SGLT-1 activity, 
respectively (Fig. 2A). This disproportionate high loss of cotransporter function at lower MOI is 
indicative of the existence of an inhibitory mechanism that can rapidly inactivate SGLT-1 at sites 
distal to the adherent bacteria. Importantly, rapid inactivation of SGLT-1 would undoubtedly 
play a crucial role in a diarrheal disease as it is responsible for daily uptake of ~6 liters of fluid 
from the normal small intestine (26).   
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SEM analysis was employed to investigate whether the disproportionately high loss of 
SGLT-1 activity at low bacterial dosages was linked to EPEC’s ability to efface microvilli from 
around the infection site (1, 2). This revealed that microvilli damage was restricted to the area 
directly below (or in very close proximity) to the adherent bacteria at 30 min, with extensive loss 
of adjacent microvilli requiring a 1 to 2 h infection (Fig. 3). Thus, it appears that EPEC possess 
an effacement-independent mechanism to rapidly inactivate SGLT-1. Furthermore, bacterial 
‘sinking’ into the brush border by 30 min with loss of adjacent microvilli a later event, is 
indicative of a two-step effacement process (Fig. 3). Notably, centrifugation did not promote 
uniform extensive adherence as most cells displayed no bacteria, single bacteria or small 
microcolonies 5 min post-centrifugation (Fig. 3) despite the MOI of ~200:1.  
 
Role for multiple LEE-encoded effectors in microvilli effacement and rapid SGLT-1 
inactivation  
Additional 30 min infections with an available quadruple (quad) mutant (Map, EspF, Tir and 
Intimin deficient) revealed the dependence of both rapid SGLT-1 inactivation and microvilli 
damage on the absent gene products. Thus, the quad mutant, unlike wild type EPEC, failed to 
induce dose-dependent decreases in SGLT-1 activity (Fig. 4A) or significant microvilli damage 
(Fig. 4B). However, while this mutant was rarely detected on Caco-2 cells (Fig. 4B) it was as 
proficient as wild type EPEC, unlike the espA translocator mutant, at delivering the EspB 
translocator/effector protein into the host cytoplasm (Fig. 4C). Thus, rapid abrogation of SGLT-1 
activity and microvilli damage are both linked to the function of one or more of the missing gene 
products. 
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Surprisingly, extended infections with the quad, but not espA (translocator defective), 
mutant triggered a slow progressive loss of SGLT-1 activity revealing a T3SS-dependent 
inhibitory mechanism. This mechanism is rather minor as a significant decrease in SGLT-1 
function is not evident until 4 h post-infection (~40%; Fig. 4D) compared to the 
Map/EspF/Tir/Intimin-mediated inhibition where ~85% of SGLT-1 function is abolished during 
a 30 min infection (Fig. 2A). However, the identification of this additional mechanism provides 
an assay to define the responsible effector(s) and underlining inhibitory mechanism(s).  
 
Cooperative roles for Map,EspF,Tir and Intimin in rapid loss of SGLT-1 activity 
Infections with mutants deleted for individual effectors revealed only minor roles for EspF, Tir 
and Intimin in inhibiting SGLT-1 activity, as cells infected with the espF, tir and eae mutants 
retained ~6%, ~13%, ~13% of the cellular activity, respectively, compared to ~1% for map- and 
wild type EPEC-infected cells (Fig 5A). Similar values for tir and eae mutants (~13%) is 
indicative of yet another Tir subversive activity dependent on prior Tir-Intimin interaction (5). 
This premise was supported by finding that the triple (trip; mapespFtir) and quad mutants, which 
differ only in Intimin expression, inhibited SGLT-1 activity to the same extent (~50%; Fig. 5A). 
Moreover, tir and eae mutants inhibiting a much greater percentage of SGLT-1 activity 
compared to the trip/quad mutants implicated participating roles for Map and/or EspF. Indeed 
redundant cooperative roles were uncovered by showing that a mapespF double mutant reduced 
SGLT-1 activity to ~35% of total levels compared to ~1% and ~6% for map and espF mutants 
(Fig. 5A). Thus, the rapid Map/EspF/Tir/Intimin-related inhibition of SGLT-1 activity involves 
the cooperative action of all four proteins. 
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Uncoupling the two-step effacement process 
SEM analysis was used to investigate the relationship between the mapespF-mediated partial 
loss of SGLT-1 activity (Fig. 5A) and microvilli damage. This revealed similar binding kinetics 
to wild type EPEC (Fig. 3 and Fig. 6A). However, bacterial ‘sinking’ into the brush border of 
Caco-2 cells (Fig. 6A), or human gastro-intestinal biopsy material (Fig. 6B), without inducing 
extensive damage to adjacent microvilli revealed essential roles for Map and EspF in extensive 
microvilli damage and that effacement was a two-step process. However, complementing this 
defect on Caco-2, but not biopsy material (not shown), by plasmid expression of Map in the 
double mutant, revealed important signaling differences between in vitro and in vivo 
differentiated cells. Moreover, the mapespF mutant defect in triggering extensive microvilli 
damage and the quad defects in this step, in addition to bacterial ‘sinking’ into the brush border 
(Fig. 4) implies that Tir/Intimin function together in the bacterial ‘sinking’ process.  
 
Discussion 
One of the most perplexing and long-standing questions in EPEC pathogenesis relates to 
the mechanism by which this pathogen employs its T3SS system to trigger the loss of absorptive 
microvilli (effacement) - a process linked to disease for over 4 decades (1, 2). In this paper we 
reveal, using the Caco-2 small intestinal epithelial model system, that effacement is a two-step 
process that requires the activity of at least three injected effector proteins (Map, EspF and Tir) 
and the Intimin outer membrane protein. The demonstrated redundant and cooperative nature of 
these molecules explains the previous lack of success in detecting roles for individual effectors in 
effacement using this model system. While infection of biopsy material has indicated possible 
roles for these same proteins in effacement (22), its capacity to unearth the described underlying 
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complexity is limited by the fact that i) strains deficient for Tir or Intimin expression bind very 
poorly to biopsy material and induce little microvilli damage and ii) a T3SS-defective mutant 
induces some microvilli damage (22). A suggestive role for EspH in effacement (22) highlight 
the possibility that other effectors may also participate in this process. However, the identified 
role of four multifunctional proteins (5) in effacement not only illustrates the complexity of 
pathogen-host interactions but also future obstacles to defining the contribution of specific 
effector functions and/or subverted cellular pathways in disease.  
The ability of a plasmid expressing Map to complement the mapespF effacement defect 
on Caco-2, but not biopsy material, was suggestive of important signaling differences between in 
vitro and in vivo differentiated cells. This is supported by the detection of putative roles for 
individual effectors in effacement with biopsy material (22) unlike the Caco-2 model system 
(data not shown). This may provide an explanation to why eae and tir mutants i) show no 
effacement defect on Caco-2 cells (5), ii) bind very poorly to biopsy material and induce little 
microvilli damage (22) and iii) fail to bind or efface in natural animal infections (7, 24) if one 
assumes that Tir/Intimin-interaction is required to unleash Map/EspF’s effacing activities. 
Indeed, the dependence of specific effector functions on Intimin interaction with Tir or non-Tir 
molecules has been demonstrated (5, 8, 12, 15, 27). Moreover, we have shown that efficient 
effector delivery can occur independently of adherence (Fig. 4C) with this is likely to occur in 
vivo as tir and eae mutants induce T3SS-dependent inflammatory responses (7, 24). Thus, the 
minor microvilli damage on biopsy material presumably reflects low EspF/Map activity in the 
absence of Tir or Intimin. In contrast, signaling differences within Caco-2 cells allow Map and 
EspF to function in a redundant manner and independently of Tir-Intimin.  
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Roles for Tir/Intimin in bacterial ‘sinking’ into the brush border and Map/EspF in 
extensive microvilli damage identifies these molecules as novel tools to study the cellular 
pathways regulating these processes. Indeed, the absence of filamentous actin in the detached 
microvillar material (Fig. 1) suggests that the actin-rich microvilli structure is retracted or 
depolymerized prior to microvilli detachment. The ready detection of retained microvillar 
material by confocal (Fig. 1), but not EM, reveals a limitation of the current EM processing 
protocol in this respect and is suggestive of a mechanism to retain microvillar material. This 
prediction is supported by SEM which frequently detects microvilli being ‘pulled’ towards the 
adherent bacteria (Fig. 3). This retention process is apparently not restricted to the model system 
as EPEC infection of biopsy material resulted in the release of lower than expected levels of 
microvilli marker, alkaline phosphatase (28, 29). Retention, even transiently, of microvilli 
material could play an important role in pathogenesis by perhaps delaying detection by the host 
defense system and/or providing growth promoting activities.  
Importantly, discovering that microvillar material is in fact retained, not released, opened 
the way to develop assays to monitor the detachment process. Our choice of the sodium-D-
glucose transporter, SGLT-1, proved to be excellent as i) EPEC inhibited SGLT-1 activity in a 
T3SS-dependent manner and ii) SGLT-1 is the major water pump in the small intestine 
responsible for the daily uptake of ~70% (~6 liters) of fluid from the normal intestine (26). 
Indeed, the finding that EPEC rapidly inhibits the activity of the apical Na+/H+ exchanger, 
NHE3, is consistent with our data (30) and is suggestive a common inhibitory mechanism. 
Crucially, EPEC’s capacity to rapidly abolish SGLT-1 activity by a mechanism unlinked to 
microvilli effacement provides a potent diarrheagenic mechanism that could account for the 
rapid onset of severe watery diarrhea (20). SGLT-1 inactivation during EPEC infection is 
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supported by severe diarrheal cases being refractory to oral rehydration therapy (ORT) (1) – a 
process that relies on the sodium/glucose cotransporter to correct electrolyte imbalance and 
promote fluid uptake (31). Indeed, the responsiveness of milder diarrheal cases to ORT (1) 
indicates that disease symptoms are related to the degree of SGLT-1 inactivation – a process that 
would depends on many factors such as bacterial inoculum size, ‘infectivity’ state (see below), 
host age, health status and host/bacterial genotypes. While EPEC undoubtedly subverts other 
cellular responses which can contribute to diarrhea, such as disruption of barrier function and 
immune response-triggered secretory responses (1, 5), these would be relatively late events 
compared to the rapid adherence-associated loss of SGLT-1 activity and thus likely to be 
secondary or additive mechanisms.  
The finding that centrifugation does not promote uniform extensive bacterial adherence 
(Fig. 3 and 6A), with the kinetics of SGLT-1 inactivation only delayed by ~60-90 min in the 
absence of pre-activation and centrifugation (not shown), illustrates that this in vitro data is very 
relevant to the in vivo situation. This is re-enforced by the fact that experimental in vivo animal 
infection studies also i) involve high bacterial inoculums with extensive binding to enterocytes 
(3, 7, 24, 32), and ii) probably involve pre-activated bacteria as signals within the gastro-
intestinal tract induce the T3SS (33) as well as a ‘hyperinfective’, presumably, pre-activated state 
(32).  
 In conclusion the dependence of the virulence-associated loss of microvilli on four LEE-
encoded effectors not only illustrates the complexity of EPEC-host interactions but also the 
future challenge of deciphering the contribution of individual effector functions or subverted 
cellular process in disease. Identifying effector functions linked with i) microvilli retraction ii) 
microvilli detachment and iii) rapid SGLT-1 inactivation (unlinked to microvilli effacement) 
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reveals the responsible bacterial proteins as new tools to probe the cellular mechanisms 
regulating these host processes. Discovering that detached microvillar material is retained not 
only reveals limitations of current EM procedures but opens the way to develop quantitative 
effacement assays. The presented data also identified an important difference between in vitro 
and in vivo differentiated cells and provides important insights into the infection process. 
Crucially, identifying that EPEC can rapidly inactivate the major water pump of the small 
intestine (SGLT-1) reveals a potent diarrheagenic mechanism to possibly explain the rapid onset 
of severe watery diarrhea (20).  
 
Materials and Methods 
 
Bacterial strains and plasmids. EPEC E2348/69, map, espF, tir and eae (Intimin) strains as 
well as the construction of the Map-expressing plasmid have previously been described or 
referenced within (8, 12, 27). Multiple mutants were generated by the sequential deletion of 
individual genes by allelic exchange using pCVD442-based suicide vectors, as previously 
described or referenced within (8, 12, 27). Deletion of each gene was confirmed by PCR and 
western blot analyses, with the latter also serving to confirm the expression and/or secretion of 
the Esp translocators as well as non-deleted Map, EspF, Tir and/or Intimin proteins. 
 
Cultured cells and infection protocol. Caco-2 cells (ATCC No. HTB-37) were cultured and 
infected as previously described (15) on 1.1 cm2 porous membrane filters (0.4 µm pore size; 
Costar, Corning Inc.) at a density of ~5 X 105 cells per filter with media replaced every 2 days 
for use 20 days post-seeding. Bacteria were pre-grown in DMEM (Dulbecco’s Minimal Eagle 
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Media; Invitrogen) for 3h without shaking to induce the effector delivery system. Culture OD600 
(1 OD600 = ~1 X 109 bacteria/ml) was measured and adjusted to the required bacterial MOI 
(multiplicity of infection) prior to adding 0.5 ml to the cell monolayers, centrifuged (500 x g; 5 
min) and incubated (37ºC; 5% CO2) for the required time. 
  
α-methyl-D-glucopyranoside (AMG) uptake assay. Measurement of SGLT-1 specific uptake 
of AMG was a modification of that previously described (34). The infected monolayers were 
washed four times with 37°C medium B (34) prior to incubating 1 h 37°C with medium B 
containing bactericidal levels of gentamycin (100µg/ml final conc). The apical medium was 
replaced with medium B containing 0.1 mM AMG for 10 min to block non-specific AMG-
binding sites before replacing with 0.1mM AMG containing 0.15µCi/mL of 14C-labelled AMG 
(methyl- -D-[U-14C] glucopyranoside; Amersham Bioscience) for 10 min. Duplicate 
experiments were carried out in the presence the SGLT-1 specific inhibitor phlorizin (0.2mM 
final conc; Sigma). AMG uptake was stopped by adding ice-cold medium B/0.2 mM phlorizin, 
washed 5 times with this solution prior to lysing in ice cold 100mM NaOH. Radioactivity levels 
(disintegrations per minute; DPM) were measured in Ultima Gold scintillation cocktail (Perkin 
Elmer) using a Tricarb 2700TR scintillation analyser (Packard). SGLT-1-mediated AMG uptake 
was the difference in radioactivity between phlorizin treated and untreated cells.  
 
Microscopy and western blot analyses. Standard techniques were employed as previously 
described (15). Antibodies used were against intestinal alkaline phosphatase (abcam; ab7322), 
SGLT-1 (Chemicon), EspF and EspB (Kenny lab.) for detection with goat anti-rabbit fluorescein 
isothiocyanate (FITC)-conjugated (Jackson) or alkaline phosphatase-conjugated (Zymed 
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Laboratories) antibodies. Polymerized actin was labeled with tetramethylrhodamine 
isothiocyanate (TRITC)-conjugated phalloidin and DNA with DAPI (Vectashield mounting 
media; Vector Laboratories Inc) (15). Western analysis (15) was with 20μg of saponin released 
(0.1% w/v) host ‘cytoplasmic’ protein fraction. 
 
In vitro organ culture. Proximal small intestinal mucosal biopsies (fourth part duodenum) were 
obtained with fully informed parental consent and local ethical committee approval using grasp 
forceps during routine endoscopic (Fujinon EG/EC-41 pediatric endoscope) investigation of 
intestinal disorders. Macroscopically normal tissue samples from five patients (aged 63, 93, 142, 
150, and 209 months) were infected for 8 h and analyzed as described previously (23). 
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Figure Legends 
Figure 1. EPEC-induced relocation of microvillous material. Caco-2 cells were left uninfected or 
apically-infected with EPEC for 2h prior to fixing and staining DNA (blue; bacteria [arrows] and 
host nuclei), polymerized actin (Red) and A) alkaline phosphatase [AP] or B) the sodium-D-
glucose cotransporter [SGLT-1] (Green - arrowheads) revealing the relocation of both AP and 
SGLT-1 from the actin-rich apical surface to a position above the adherent bacteria. Images are 
composites of sequential sections taken at 2μm intervals with inset (A) showing a magnified 
view of the boxed region. Note the large intracellular pool of SGLT-1 that constitutes up to two-
thirds of the cellular total (35) and the altered distribution following EPEC infection.  
 
Figure 2. Rapid T3SS-dependent inactivation of the sodium-D-glucose cotransporter (SGLT-1). 
Import of the non-metabolisable glucose analogue 14C-labelled AMG (disintegrations per 
minute; DPM) by SGLT-1 is inhibited by EPEC, but not the effector delivery mutant espA, in a 
dose-dependent manner - n=3; mean ± SE; Statistical significance [*] between uninfected and 
indicated infected series (horizontal lines) determined by one-way ANOVA with a post-hoc 
Tukey test revealing where significance lies. B) Percentage of the apical surface covered by 
EPEC following a 30 min infection at the indicated MOI (Multiplicity of infection, EPEC:host 
cell) quantified following scanning electron microscopy evaluation (n=3; mean ± SE). 
 
Figure 3. Kinetics of EPEC-induced microvilli damage. SEM analysis reveals that centrifugation 
of pre-activated EPEC (MOI ~200:1) does not promote uniform extensive adherence to 
differentiated Caco-2 cells as most cells have no bacteria, single bacteria or small microcolonies 
5 min post-centrifugation. However, by 30 min small microcolonies are more evident with 
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bacteria appearing to ‘sink’ (arrowheads) into the brush border. Importantly, loss of microvilli 
from around the infection site occurs at later times with microvilli appearing to be ‘pulled’ 
towards the bacteria (arrows). Extensive loss of microvilli from around the infection site is 
evident by 2 h with practically all microvilli lost by 4 h.  
 
Figure 4. Microvilli effacement and rapid SGLT-1 inactivation are linked to the cooperative 
activities of Map, EspF, Tir and Intimin. Differentiated Caco-2 cells were infected with wild type 
EPEC (WT), quadruple mutant (quad; Map,EspF,Tir,Intimin deficient) or espA (translocator 
defective) mutant (MOI ~200:1, unless otherwise indicated) for the stated times prior to 
processing for SGLT-1 activity (A, D), SEM (B) or western blot analysis (C). Uptake of the non-
metabolisable glucose analogue 14C-labelled AMG (disintegrations per minute; DPM) following 
30 min infections reveal that wild type EPEC, but not the quad mutant, triggers a dose-dependent 
loss of SGLT-1 activity (A) though prolonged quad infections induce a progressive effector 
delivery-dependent loss of SGLT-1 activity (D) - n=3; mean ± SE; Statistical significance [*] 
between uninfected and indicated infected sets (horizontal lines; A) or between indicated sets (D) 
determined by one-way ANOVA with a post-hoc Tukey test revealing where significance lies. 
SEM reveals that the quad mutant rarely binds Caco-2 cells and does not induce significant 
microvillar damage (B).  However, the ability of the quad, but not espA (translocator defective), 
mutant to deliver the EspB translocator/effector protein into host cells in similar amounts and at 
a comparable rate to the wild type strain (C) indicates a role for one or more of the missing gene 
products in microvilli damage and rapid SGLT-1 inactivation.  
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Figure 5. Map, EspF, Tir and Intimin function together to inhibit SGLT-1 function. 
Differentiated Caco-2 cells were infected for 6 h with wild type EPEC, the espA translocator 
mutant or strains deleted for one or more of the map, espF, tir and eae (Intimin) genes prior to 
assesses SGLT-1 activity by measuring uptake of the non-metabolisable glucose analogue 14C-
labelled AMG (disintegrations per minute; DPM). This reveals i) minor roles for EspF, Tir and 
Intimin, ii) redundant co-operative roles for Map and EspF, iii) a role for Tir-Intimin interaction 
and iv) all four proteins function together to inhibit SGLT-1 function - n=3; mean ± SE; 
Statistical significance [*] between indicated pairs (horizontal lines) determined using Student t-
test. Note the ~50% loss of SGLT-1 activity with quad/trip mutant (differ only in Intimin 
expression) is due to a slow Map/EspF/Tir/Intimin-independent mechanism (Fig. 4).  
 
Figure 6. Uncoupling the two-step effacement process. Centrifugation of the pre-activated 
mapespF double mutant onto differentiated Caco-2 cells, like EPEC (Fig. 3), does not promote 
uniform extensive adherence despite the initial MOI of ~200:1 (EPEC:host cells). Whilst 
adherence is once again linked to bacteria ‘sinking’ into the brush border the double mutant, 
unlike wild type EPEC (Fig. 3), does not trigger extensive microvilli damage (Fig. 6A). A 
similar defect is reproduced with human gastro-intestinal biopsy tissue (B). Thus, effacement is a 
two-step effacement process where Map and EspF function to induce the extensive loss of 
microvilli.  
 






